Clinical Trials · NCT06592261
Graded Insulin Suppression Test P&F
- Phase
- Phase 1
- Recruitment status
- Completed
- Sponsor
- Columbia University
- Enrollment
- 20
- Start date
- Sep 2024
- Locations
- 1 site, United States
- Primary endpoint
- Steady-state plasma glucose at euinsulinemia (ESS-G)